ASN
FMED icon

Advisory Services Network’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Advisory Services Network’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-110
Closed -$2.66K – 2230
2023
Q4 		$2.66K Buy
+110
New +$2.39K ﹤0.01% 3314

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisory Services Network's FMED Position: Q1 2024 in Review

Advisory Services Network sold out of Fidelity Disruptive Medicine ETF (FMED) in Q1 2024, closing a stake of 110 shares — an estimated $2.66K sold.

Advisory Services Network first reported a position in FMED in Q4 2023 and held it in 1 quarter. The position peaked at $2.66K in Q4 2023. 8 funds tracked by Wall St. Rank hold FMED as of Q1 2024.

  • Advisory Services Network reported no remaining Fidelity Disruptive Medicine ETF position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 110 Fidelity Disruptive Medicine ETF shares in Q1 2024, an estimated $2.66K.
  • Advisory Services Network first reported a position in Fidelity Disruptive Medicine ETF in Q4 2023 and held it in 1 quarter.
  • Advisory Services Network's Fidelity Disruptive Medicine ETF position peaked at $2.66K in Q4 2023.
  • 8 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.